(VIANEWS) – BRF S.A. (BRFS), Helios Technologies (HLIO), TravelCenters of America LLC (TA) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. BRF S.A. (BRFS)

60.7% sales growth and 19.12% return on equity

BRF S.A. focuses on raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, and other products.

BRF S.A.’s sales growth this year is expected to be 16.7% and 5% for next year.

Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 41.11B for the twelve trailing months.

Volume

Today’s last reported volume for BRF S.A. is 3161810 which is 26.96% below its average volume of 4329320.

BRF S.A.’s sales growth for the next quarter is 60.7%. The company’s growth estimates for the present quarter and the next is 300% and negative -28.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.12%.

BRF S.A.’s Stock Yearly Top and Bottom Value

BRF S.A.’s stock is valued at $4.31 at 20:22 EST, way under its 52-week high of $6.08 and way above its 52-week low of $2.85.

BRF S.A.’s Moving Average

BRF S.A.’s value is way under its 50-day moving average of $4.93 and below its 200-day moving average of $4.64.

2. Helios Technologies (HLIO)

51.5% sales growth and 9.18% return on equity

Helios Technologies, Inc., together with its subsidiaries, develops, manufactures, and sells solutions for the hydraulics and electronics markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Helios Technologies’s sales growth this year is anticipated to be 45.5% and 7.9% for next year.

Year-on-year quarterly revenue growth grew by 58.2%, now sitting on 598.4M for the twelve trailing months.

Volume

Today’s last reported volume for Helios Technologies is 49186 which is 47.51% below its average volume of 93706.

Helios Technologies’s sales growth for the next quarter is 51.5%. The company’s growth estimates for the present quarter and the next is 56.4% and 56.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.18%.

Volatility

Helios Technologies’s last day, last week, and last month’s current volatility was 0.07%, 1.65%, and 1.46%, respectively.

Helios Technologies’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.64% (day), 2.93% (last week), and 2.83% (last month), respectively.

Helios Technologies’s Stock Yearly Top and Bottom Value

Helios Technologies’s stock is valued at $83.67 at 20:22 EST, under its 52-week high of $86.42 and way above its 52-week low of $35.40.

Helios Technologies’s Moving Average

Helios Technologies’s value is above its 50-day moving average of $79.24 and way above its 200-day moving average of $72.46.

3. TravelCenters of America LLC (TA)

49.6% sales growth and 4.03% return on equity

TravelCenters of America Inc. operates travel centers and standalone restaurants in the United States and Canada.

TravelCenters of America LLC’s sales growth this year is expected to be 47.1% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 86%, now sitting on 5.92B for the twelve trailing months.

Volume

Today’s last reported volume for TravelCenters of America LLC is 52557 which is 66.88% below its average volume of 158696.

TravelCenters of America LLC’s sales growth is a negative 0% for the present quarter and 49.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 0% and 98.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.03%.

Volatility

TravelCenters of America LLC’s last day, last week, and last month’s current volatility was 0.61%, 3.49%, and 4.41%, respectively.

TravelCenters of America LLC’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.63% (day), 5.03% (last week), and 5.55% (last month), respectively.

TravelCenters of America LLC’s Stock Yearly Top and Bottom Value

TravelCenters of America LLC’s stock is valued at $36.43 at 20:22 EST, below its 52-week high of $39.59 and way higher than its 52-week low of $16.94.

TravelCenters of America LLC’s Moving Average

TravelCenters of America LLC’s worth is way above its 50-day moving average of $32.16 and way higher than its 200-day moving average of $28.98.

4. Illumina (ILMN)

46.2% sales growth and 13.18% return on equity

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.

Illumina’s sales growth this year is anticipated to be 34.4% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 27.2%, now sitting on 3.47B for the twelve trailing months.

Volume

Today’s last reported volume for Illumina is 1105600 which is 75.42% above its average volume of 630230.

Illumina’s sales growth for the next quarter is 46.2%. The company’s growth estimates for the present quarter and the next is 119.4% and 33.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.18%.

Volatility

Illumina’s last day, last week, and last month’s current volatility was 8.56%, 2.82%, and 1.64%, respectively.

Illumina’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.41% (day), 2.72% (last week), and 2.26% (last month), respectively.

Illumina’s Stock Yearly Top and Bottom Value

Illumina’s stock is valued at $486.71 at 20:22 EST, way under its 52-week high of $555.77 and way higher than its 52-week low of $260.42.

Illumina’s Moving Average

Illumina’s worth is under its 50-day moving average of $489.71 and way higher than its 200-day moving average of $437.41.

5. Maximus (MMS)

17.3% sales growth and 21.75% return on equity

MAXIMUS, Inc. provides business process services (BPS) to government health and human services programs worldwide.

Maximus’s sales growth this year is anticipated to be 22.3% and a negative 2.6% for next year.

Year-on-year quarterly revenue growth grew by 17.3%, now sitting on 3.73B for the twelve trailing months.

Volume

Today’s last reported volume for Maximus is 297276 which is 7.55% above its average volume of 276401.

Maximus’s sales growth is a negative 0% for the current quarter and 17.3% for the next. The company’s growth estimates for the current quarter and the next is 3.8% and negative -16.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.75%.

Volatility

Maximus’s last day, last week, and last month’s current volatility was 2.95%, 1.14%, and 1.07%, respectively.

Maximus’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.91% (day), 2.22% (last week), and 2.02% (last month), respectively.

Maximus’s Stock Yearly Top and Bottom Value

Maximus’s stock is valued at $83.59 at 20:22 EST, way below its 52-week high of $96.05 and way above its 52-week low of $64.30.

Maximus’s Moving Average

Maximus’s value is below its 50-day moving average of $86.65 and below its 200-day moving average of $88.13.

6. Globus Medical (GMED)

5.7% sales growth and 8.31% return on equity

Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders.

Globus Medical’s sales growth this year is expected to be 20.7% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 19.3%, now sitting on 825.81M for the twelve trailing months.

Volume

Today’s last reported volume for Globus Medical is 21435 which is 94.91% below its average volume of 421206.

Globus Medical’s sales growth for the next quarter is 5.7%. The company’s growth estimates for the ongoing quarter and the next is 528.6% and negative -8.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.31%.

Volatility

Globus Medical’s last day, last week, and last month’s current volatility was 0.14%, 0.73%, and 1.08%, respectively.

Globus Medical’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.95% (day), 1.86% (last week), and 2.02% (last month), respectively.

Globus Medical’s Stock Yearly Top and Bottom Value

Globus Medical’s stock is valued at $78.06 at 20:22 EST, under its 52-week high of $83.94 and way above its 52-week low of $48.00.

Globus Medical’s Moving Average

Globus Medical’s worth is below its 50-day moving average of $80.04 and way higher than its 200-day moving average of $70.72.

LEAVE A REPLY

Please enter your comment!
Please enter your name here